TD Cowen lowered the firm’s price target on Clorox (CLX) to $98 from $111 and keeps a Hold rating on the shares. The firm reduced estimates in the household and personal care space, saying the companies will be unable to fully mitigate higher oil-related input costs stemming from the Iran war. Even if the conflict ends soon, the price increases “will prove sticky due to infrastructure damage,” the analyst tells investors in a research note. TD cites declining pricing power relative to history and less opportunity to trade up consumers to super-premium products for the target cuts.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLX:
- Clorox price target lowered to $101 from $112 at Deutsche Bank
- Clorox Secures New Credit Facilities for GOJO Acquisition
- Clorox: Margin Recovery Achieved but Ambitious Growth Targets Keep Rating at Hold
- Clorox price target raised to $124 from $112 at BofA
- Clorox price target raised to $125 from $115 at Wells Fargo
